New member | Therenva
Therenva SAS, based in Rennes, designs, develops and markets innovative software solutions for planning and navigating endovascular procedures based on... View Article
Atlanpole Biotherapies gathered its members together on 28th February for its General Meeting
150 people were in attendance at the cluster’s “assessment and goals” day: 12 new members pitched: Hera-Mi, Biologbook, Bee Healthcare, ARS... View Article
A fantastic edition of the Bioregate Forum 2018 in Nantes
The International Forum for those involved in regenerative medicine took place on 12th-14th December in Nantes. It was attended by... View Article
Students from Nantes are competing for the prestigious MIT iGEM prize | Support them on this adventure !
15 students from the Nantes faculty of science and technology have formed the first team from Western France to take... View Article
CLEAN CELLS® acquires BE VACCINES
Clean Cells, a company founded in 2000, as the result of academic research, and an original member of Atlanpole Biotherapies,... View Article
Valneva | 2018 Results and Growth in 2019
Valneva Reports Strong 2018 Results, Expects Further Growth and Major Pipeline Progression in 2019 Major R&D milestones achieved in 2018,... View Article
Clean Cells opened its capital to ArchiMed to support its growth strategy in the biopharmaceutical sector
The biopharmaceutical services company Clean Cells, specialized in biosafety testing and cell bank and virus seed stock production, has reached... View Article
Emergent BioSolutions and Valneva Report Positive Phase 1 Results for their Vaccine Candidate Against the Zika Virus
EMERGENT BIOSOLUTIONS AND VALNEVA REPORT POSITIVE PHASE 1 RESULTS FOR THEIR VACCINE CANDIDATE AGAINST THE ZIKA VIRUS GAITHERSBURG, Md. and... View Article
Telix Pharmaceuticals Completes Acquisition of Atlab Pharma
Telix Pharmaceuticals Limited (“Telix”, the “Company”) today announced the completion of the acquisition of Atlab Pharma SAS (“Atlab”). The option... View Article
Samabriva and Affilogic entered into an Option and License Agreement to develop Nanofitin®-conjugated biotherapeutics to treat Lysosomal Storage Disorders
Amiens, France, and Nantes, France, September 10, 2018 – Samabriva and Affilogic jointly announced that they recently entered into an... View Article